Medications

Analysis hints at sudden cardiac death reduction with finerenone

Finerenone does not reduce the risk of all-cause death in patients with type 2 diabetes and kidney disease but does lower the likelihood of sudden cardiac death, according to late breaking research presented in a Hot Line ...

Inflammatory disorders

Comorbidities up among patients with ESRD, concomitant psoriasis

For patients with end-stage renal disease (ESRD), those with concomitant psoriasis are younger and more often have cancer, diabetes mellitus, and coronary artery disease, according to a study published online July 26 in the ...

Cardiology

New light on association between diabetes and heart valve disease

Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves compared to controls without diabetes, a comprehensive register study at the University of Gothenburg shows. The statistical ...

Medications

Tirzepatide improves kidney outcomes in T2DM with increased CV risk

An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new onset of macroalbuminuria; ...

page 1 from 31